533 related articles for article (PubMed ID: 18027540)
1. Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA): findings from a pilot study.
Rosenthal M; Moore P; Groves E; Iwan T; Schlosser LG; Dziewanowska Z; Negro-Vilar A
J Opioid Manag; 2007; 3(3):145-54. PubMed ID: 18027540
[TBL] [Abstract][Full Text] [Related]
2. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain.
Rauck RL; Bookbinder SA; Bunker TR; Alftine CD; Ghalie R; Negro-Vilar A; de Jong E; Gershon S
J Opioid Manag; 2006; 2(3):155-66. PubMed ID: 17319449
[TBL] [Abstract][Full Text] [Related]
3. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial.
Rauck RL; Bookbinder SA; Bunker TR; Alftine CD; Ghalie R; Negro-Vilar A; de Jong E; Gershon S
J Opioid Manag; 2006; 2(6):325-8, 331-3. PubMed ID: 17326594
[TBL] [Abstract][Full Text] [Related]
4. Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain.
Katz N; Hale M; Morris D; Stauffer J
Postgrad Med; 2010 Jul; 122(4):112-28. PubMed ID: 20675975
[TBL] [Abstract][Full Text] [Related]
5. Effects of extended-release tramadol on pain-related sleep parameters in patients with osteoarthritis.
Florete OG; Xiang J; Vorsanger GJ
Expert Opin Pharmacother; 2008 Aug; 9(11):1817-27. PubMed ID: 18627321
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial.
Caldwell JR; Rapoport RJ; Davis JC; Offenberg HL; Marker HW; Roth SH; Yuan W; Eliot L; Babul N; Lynch PM
J Pain Symptom Manage; 2002 Apr; 23(4):278-91. PubMed ID: 11997197
[TBL] [Abstract][Full Text] [Related]
7. A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions--the ACCPT Study.
Adams EH; Chwiecko P; Ace-Wagoner Y; Mangefrida B; Duerden ME; Perdikis GC; Kunkel FA; Ghalie R
Pain Pract; 2006 Dec; 6(4):254-64. PubMed ID: 17129306
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
Hale M; Tudor IC; Khanna S; Thipphawong J
Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
Karlsson M; Berggren AC
Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting dosing regimens of morphine sulfate extended-release (KADIAN) capsules.
Weil AJ; Nicholson B; Sasaki J
J Opioid Manag; 2009; 5(1):39-45. PubMed ID: 19344047
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of morning vs. evening dosing of extended-release hydromorphone on sleep physiology in patients with low back pain: a pilot study.
Webster LR; Smith MD; Mackin S; Iverson M
Pain Med; 2015 Mar; 16(3):460-71. PubMed ID: 25279807
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
Nicholson B; Ross E; Sasaki J; Weil A
Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
[TBL] [Abstract][Full Text] [Related]
13. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
14. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
Ridgway D; Sopata M; Burneckis A; Jespersen L; Andersen C
J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
[TBL] [Abstract][Full Text] [Related]
16. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients.
Vorsanger G; Xiang J; Jordan D; Farrell J
Clin Ther; 2007; 29 Suppl():2520-35. PubMed ID: 18164919
[TBL] [Abstract][Full Text] [Related]
17. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
[TBL] [Abstract][Full Text] [Related]
18. A randomized, open-label, multicenter trial comparing once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: improved physical functioning in the ACTION trial.
Rauck RL; Bookbinder SA; Bunker TR; Alftine CD; Gershon S; de Jong E; Negro-Vilar A; Ghalie R
J Opioid Manag; 2007; 3(1):35-43. PubMed ID: 17367093
[TBL] [Abstract][Full Text] [Related]
19. Avinza - 24-h sustained-release oral morphine therapy.
Caldwell JR
Expert Opin Pharmacother; 2004 Feb; 5(2):469-72. PubMed ID: 14996642
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules.
Nicholson B; Ross E; Weil A; Sasaki J; Sacks G
Curr Med Res Opin; 2006 Mar; 22(3):539-50. PubMed ID: 16574037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
